Genomic Tools

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Since most mRNA and microRNA (miRNA) are known, and can be assessed using arrays or RNAseq, they offer unique insight into the molecular biology of ischemic stroke and hemorrhage. Although no one blood mRNA or miRNA can diagnose stroke or hemorrhage, panels or profiles of mRNAs/miRNA can distinguish ischemic stroke from intracerebral hemorrhage and control patients. There are also specific profiles of mRNA and miRNA in blood for large-vessel, cardioembolic, and lacunar causes of stroke that can be used to predict the causes of cryptogenic stroke. There are also specific profiles for patients with ischemic compared with nonischemic transient neurological events, and profiles within 3. h of a stroke that predict which patients will develop hemorrhagic transformation following tissue plasminogen activator.

Original languageEnglish (US)
Title of host publicationPrimer on Cerebrovascular Diseases
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages343-345
Number of pages3
ISBN (Print)9780128030585
DOIs
StatePublished - Mar 7 2017

Fingerprint

MicroRNAs
Stroke
Messenger RNA
Hemorrhage
Lacunar Stroke
Cerebral Hemorrhage
Tissue Plasminogen Activator
Blood Vessels
Molecular Biology

Keywords

  • Alternative splicing
  • Arrays
  • Blood
  • Genomics
  • Intracerebral hemorrhage
  • MiRNA
  • MRNA
  • RNAseq
  • Stroke
  • Stroke causes
  • TIAs

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Sharp, F. R., Jickling, G. C., & Stamova, B. (2017). Genomic Tools. In Primer on Cerebrovascular Diseases: Second Edition (pp. 343-345). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803058-5.00072-2

Genomic Tools. / Sharp, Frank R; Jickling, G. C.; Stamova, Boryana.

Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., 2017. p. 343-345.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sharp, FR, Jickling, GC & Stamova, B 2017, Genomic Tools. in Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., pp. 343-345. https://doi.org/10.1016/B978-0-12-803058-5.00072-2
Sharp FR, Jickling GC, Stamova B. Genomic Tools. In Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc. 2017. p. 343-345 https://doi.org/10.1016/B978-0-12-803058-5.00072-2
Sharp, Frank R ; Jickling, G. C. ; Stamova, Boryana. / Genomic Tools. Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., 2017. pp. 343-345
@inbook{e3c93f3924f143a69d75ead973077794,
title = "Genomic Tools",
abstract = "Since most mRNA and microRNA (miRNA) are known, and can be assessed using arrays or RNAseq, they offer unique insight into the molecular biology of ischemic stroke and hemorrhage. Although no one blood mRNA or miRNA can diagnose stroke or hemorrhage, panels or profiles of mRNAs/miRNA can distinguish ischemic stroke from intracerebral hemorrhage and control patients. There are also specific profiles of mRNA and miRNA in blood for large-vessel, cardioembolic, and lacunar causes of stroke that can be used to predict the causes of cryptogenic stroke. There are also specific profiles for patients with ischemic compared with nonischemic transient neurological events, and profiles within 3. h of a stroke that predict which patients will develop hemorrhagic transformation following tissue plasminogen activator.",
keywords = "Alternative splicing, Arrays, Blood, Genomics, Intracerebral hemorrhage, MiRNA, MRNA, RNAseq, Stroke, Stroke causes, TIAs",
author = "Sharp, {Frank R} and Jickling, {G. C.} and Boryana Stamova",
year = "2017",
month = "3",
day = "7",
doi = "10.1016/B978-0-12-803058-5.00072-2",
language = "English (US)",
isbn = "9780128030585",
pages = "343--345",
booktitle = "Primer on Cerebrovascular Diseases",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Genomic Tools

AU - Sharp, Frank R

AU - Jickling, G. C.

AU - Stamova, Boryana

PY - 2017/3/7

Y1 - 2017/3/7

N2 - Since most mRNA and microRNA (miRNA) are known, and can be assessed using arrays or RNAseq, they offer unique insight into the molecular biology of ischemic stroke and hemorrhage. Although no one blood mRNA or miRNA can diagnose stroke or hemorrhage, panels or profiles of mRNAs/miRNA can distinguish ischemic stroke from intracerebral hemorrhage and control patients. There are also specific profiles of mRNA and miRNA in blood for large-vessel, cardioembolic, and lacunar causes of stroke that can be used to predict the causes of cryptogenic stroke. There are also specific profiles for patients with ischemic compared with nonischemic transient neurological events, and profiles within 3. h of a stroke that predict which patients will develop hemorrhagic transformation following tissue plasminogen activator.

AB - Since most mRNA and microRNA (miRNA) are known, and can be assessed using arrays or RNAseq, they offer unique insight into the molecular biology of ischemic stroke and hemorrhage. Although no one blood mRNA or miRNA can diagnose stroke or hemorrhage, panels or profiles of mRNAs/miRNA can distinguish ischemic stroke from intracerebral hemorrhage and control patients. There are also specific profiles of mRNA and miRNA in blood for large-vessel, cardioembolic, and lacunar causes of stroke that can be used to predict the causes of cryptogenic stroke. There are also specific profiles for patients with ischemic compared with nonischemic transient neurological events, and profiles within 3. h of a stroke that predict which patients will develop hemorrhagic transformation following tissue plasminogen activator.

KW - Alternative splicing

KW - Arrays

KW - Blood

KW - Genomics

KW - Intracerebral hemorrhage

KW - MiRNA

KW - MRNA

KW - RNAseq

KW - Stroke

KW - Stroke causes

KW - TIAs

UR - http://www.scopus.com/inward/record.url?scp=85028290304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028290304&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803058-5.00072-2

DO - 10.1016/B978-0-12-803058-5.00072-2

M3 - Chapter

AN - SCOPUS:85028290304

SN - 9780128030585

SP - 343

EP - 345

BT - Primer on Cerebrovascular Diseases

PB - Elsevier Inc.

ER -